This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Mar 21;143(12):1064-1065.

doi: 10.1182/blood.2023023626.

C5 inhibition in PNH: still effective and safe

Jeff Szer¹

Affiliations

PMID: 38512266
DOI: 10.1182/blood.2023023626

Free article

Editorial

C5 inhibition in PNH: still effective and safe

Jeff Szer. Blood. 2024.

Free article

. 2024 Mar 21;143(12):1064-1065.

doi: 10.1182/blood.2023023626.

Author

Jeff Szer¹

Affiliation

¹ The Royal Melbourne Hospital.

PMID: 38512266
DOI: 10.1182/blood.2023023626

No abstract available

PubMed Disclaimer

Comment on

Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
Kelly RJ, Holt M, Vidler J, Arnold LM, Large J, Forrest B, Barnfield C, Pike A, Griffin M, Munir T, Muus P, Nagumantry SK, Varghese A, Davies JR, Trikha R, Kulasekararaj AG, Mitchell L, Gandhi S. Kelly RJ, et al. Blood. 2024 Mar 21;143(12):1157-1166. doi: 10.1182/blood.2023021762. Blood. 2024. PMID: 38142401

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Miscellaneous
- NCI CPTAC Assay Portal